These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8169401)

  • 1. Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Pakuts A; Cameron DW
    J Infect Dis; 1994 May; 169(5):1103-7. PubMed ID: 8169401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.
    Sahai J; Gallicano K; Garber G; Pakuts A; Cameron W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):54-60. PubMed ID: 7648285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Garber G; Pakuts A; Hawley-Foss N; Huang L; McGilveray I; Cameron DW
    Clin Pharmacol Ther; 1992 Nov; 52(5):464-70. PubMed ID: 1424420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.
    Gallicano KD; Sahai J; Shukla VK; Seguin I; Pakuts A; Kwok D; Foster BC; Cameron DW
    Br J Clin Pharmacol; 1999 Aug; 48(2):168-79. PubMed ID: 10417493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.
    Morse GD; Portmore AC; Marder V; Plank C; Olson J; Taylor C; Bonnez W; Reichman RC
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus.
    Lertora JJ; Rege AB; Greenspan DL; Akula S; George WJ; Hyslop NE; Agrawal KC
    Clin Pharmacol Ther; 1994 Sep; 56(3):272-8. PubMed ID: 7924122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
    Moore KH; Raasch RH; Brouwer KL; Opheim K; Cheeseman SH; Eyster E; Lemon SM; van der Horst CM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2732-7. PubMed ID: 8593010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine.
    Lee BL; Täuber MG; Sadler B; Goldstein D; Chambers HF
    Clin Pharmacol Ther; 1996 Jan; 59(1):14-21. PubMed ID: 8549029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
    Gallicano K; Sahai J; Swick L; Seguin I; Pakuts A; Cameron DW
    Clin Infect Dis; 1995 Oct; 21(4):1008-11. PubMed ID: 8645788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.
    Tartaglione TA; Collier AC; Opheim K; Gianola FG; Benedetti J; Corey L
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2225-31. PubMed ID: 1803995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.
    Trapnell CB; Narang PK; Li R; Lavelle JP
    Ann Intern Med; 1996 Mar; 124(6):573-6. PubMed ID: 8597321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of zidovudine alone and in combination with oxazepam in the HIV infected patient.
    Mole L; Israelski D; Bubp J; O'Hanley P; Merigan T; Blaschke T
    J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):56-60. PubMed ID: 8417175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection.
    Morse GD; Olson J; Portmore A; Taylor C; Plank C; Reichman RC
    Antiviral Res; 1989 Mar; 11(2):57-65. PubMed ID: 2729955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of indomethacin and naproxen on zidovudine pharmacokinetics.
    Barry M; Howe J; Back D; Breckenridge A; Brettle R; Mitchell R; Beeching NJ; Nye FJ
    Br J Clin Pharmacol; 1993 Jul; 36(1):82-5. PubMed ID: 8373716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of zidovudine in HIV-positive patients with liver disease.
    Bareggi SR; Cinque P; Mazzei M; D'Arminio A; Ruggieri A; Pirola R; Nicolin A; Lazzarin A
    J Clin Pharmacol; 1994 Jul; 34(7):782-6. PubMed ID: 7929874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients.
    Van Harken DR; Pei JC; Wagner J; Pike IM
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2480-3. PubMed ID: 9371353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.
    Barry M; Howe JL; Back DJ; Swart AM; Breckenridge AM; Weller IV; Beeching N; Nye F
    Br J Clin Pharmacol; 1994 Jan; 37(1):7-12. PubMed ID: 8148221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients.
    Sahai J; Gallicano K; Ormsby E; Garber G; Cameron DW
    AIDS; 1994 Jun; 8(6):793-6. PubMed ID: 8086138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic disposition of zidovudine during pregnancy.
    Watts DH; Brown ZA; Tartaglione T; Burchett SK; Opheim K; Coombs R; Corey L
    J Infect Dis; 1991 Feb; 163(2):226-32. PubMed ID: 1988507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.